Steve Seung-Young Lee, PhD

Steve Seung-Young Lee received his B.S. degree from the Department of Chemical Engineering at Hongik University (South Korea) in 2004. He then received his M.S. degree from the Department of Materials Science and Engineering at Gwangju Institute of Science and Technology (GIST) (South Korea). After working as a research associate at Korea Institute of Science and Technology (KIST) (South Korea), he joined the Ph.D. program at the Department of Biomedical Engineering at Purdue University (West Lafayette, IN). After successful doctoral training, he moved to the University of Chicago (Chicago, IL) for his postdoctoral research. His postdoctoral research was to develop a multiplex three-dimensional imaging cytometry for tumor immunology and immunotherapy. Now he is an Assistant Professor in the Department of Pharmaceutical Sciences/College of Pharmacy at UIC. To date, he has received multiple awards and grants including NIH NIGMS R35, NIH NIBIB K99/R00, and Susan G. Komen fellowship. He has published 34 peer-reviewed papers, 3 book chapter, and 5 technical patents.

• Steve Seung-Young Lee on PubMed

Active

NIH/NIGMS MIRA for ESI (R35) (PI: S.S.-Y. Lee)  09/21-09/26

“Integrated three-dimensional (3D) microscopy for a spatial pharmacology atlas of macromolecular drugs in the tissue microenvironment”

NIH/NIGMS Diversity supplements (PI: S.S.-Y. Lee) 03/22-03/24

“Diversity Supplement_Integrated three-dimensional (3D) microscopy for a spatial pharmacology atlas of macromolecular drugs in the tissue microenvironment”

NIH/NIGMS Adminstrative supplements (PI: S.S.-Y. Lee)  09/22

“Adminstrative Supplement_Integrated three-dimensional (3D) microscopy for a spatial pharmacology   atlas of macromolecular drugs in the tissue microenvironment”

UI Cancer Center Pilot Study Award (Multi-PI: S. Jun, S.S.-Y. Lee, K. Hoskins) 05/23-04/24

"Microbiome-tumor-axis and multi-omics to identify molecular mechanisms of breast cancer disparities"

NIH/NHLBI R01 (PI: G.Y. Park, Co-I: S.S.-Y. Lee)  04/21-03/26

“Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation”

DoD Ovarian Cancer Teal Innovator Award (PI: J.E. Burdette, Co-I: S.S.-Y. Lee)  09/22-08/25

“PAX8 as a Drug Target for High-Grade Serous Cancer”

NIH/NCI IMAT R33 (PI: A. Karginov, Co-I: S.S.-Y. Lee)  03/22-02/25

“Optogenetic Control of Tumor Initiation and Tumor Progression in vivo”

NIH/NHLBI R21 (PI: Z. Zhao, Co-I: S.S-Y. Lee) 07/23-06/25

"Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury"

Completed

Susan G. Komen for the Cure Postdoctoral Fellowship, PDF15333618 (PI: S.S-Y. Lee)  08/15-07/18

“Radiation-enhanced immunotherapy for recurrent and metastatic breast cancer”

NIH Pathway to Independence Award (K99/R00), K99 (PI: S.S.-Y. Lee)  04/17-10/18

“Transparent Tumor Tomography (T3): Multi-parameter 3D imaging for tumor immunotherapy”

University of Illinois Cancer Center Pilot Program (Multi-PI: S.S.-Y. Lee)  09/20-08/21

“Single-cell spatial proteomics for geographic profiling of protein expression in ovarian tumors”

NIH/NIBIB Pathway to Independence Award (K99/R00), R00 (PI: S.S.-Y. Lee)  03/19-04/22

“Transparent Tumor Tomography (T3): Multi-parameter 3D imaging for tumor immunotherapy”